APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceutical Excipients

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biopharmaceutical Excipients Industry Growth and Trends Forecast to 2032

29 December 2025100 pages

Choose your research edition.

Industry ResearchBiopharmaceutical Excipients Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceutical Excipients Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Biopharmaceutical Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceutical Excipients Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceutical Excipients Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Biopharmaceutical Excipients market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biopharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biopharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biopharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biopharmaceutical Excipients include BASF SE, ABITEC Corp, Colorcon, Inc, DFE Pharma, Meggle AG, Pharmonix Biological, Roquette, Sigachi Industries and Signet Chemical Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biopharmaceutical Excipients market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biopharmaceutical Excipients market size, estimates, and forecasts are presented in terms of sales volume (K Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biopharmaceutical Excipients market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biopharmaceutical Excipients.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Biopharmaceutical Excipients market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biopharmaceutical Excipients Market by Company

BASF SE

ABITEC Corp

Colorcon, Inc

DFE Pharma

Meggle AG

Pharmonix Biological

Roquette

Sigachi Industries

Signet Chemical Corporation

Spectrum Chemical Manufacturing Corp

SPI Pharma

Biopharmaceutical Excipients Segment by Type

Polyols

Carbohydrates

Solubilizers& Surfactants/Emulsifiers

Other

Biopharmaceutical Excipients Segment by Application

Biopharmaceutical Downstream

Biopharmaceutical Upstream

Biopharmaceutical Excipients Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical Excipients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biopharmaceutical Excipients manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Biopharmaceutical Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Polyols Table 2. Major Company of Carbohydrates Table 3. Major Company of Solubilizers& Surfactants/Emulsifiers Table 4. Major Company of Other Table 5. Global Biopharmaceutical Excipients Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Biopharmaceutical Excipients Sales by Type (2021-2026) & (K Tons) Table 7. Global Biopharmaceutical Excipients Sales Market Share in Volume by Type (2021-2026) Table 8. Global Biopharmaceutical Excipients Sales by Type (2021-2026) & (US$ Million) Table 9. Global Biopharmaceutical Excipients Sales Market Share in Value by Type (2021-2026) Table 10. Global Biopharmaceutical Excipients Price by Type (2021-2026) & (US$/Ton) Table 11. Global Biopharmaceutical Excipients Sales by Type (2027-2032) & (K Tons) Table 12. Global Biopharmaceutical Excipients Sales Market Share in Volume by Type (2027-2032) Table 13. Global Biopharmaceutical Excipients Sales by Type (2027-2032) & (US$ Million) Table 14. Global Biopharmaceutical Excipients Sales Market Share in Value by Type (2027-2032) Table 15. Global Biopharmaceutical Excipients Price by Type (2027-2032) & (US$/Ton) Table 16. North America Biopharmaceutical Excipients Sales by Type (2021-2026) & (K Tons) Table 17. North America Biopharmaceutical Excipients Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Biopharmaceutical Excipients Sales by Type (2021-2026) & (K Tons) Table 19. Europe Biopharmaceutical Excipients Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Biopharmaceutical Excipients Sales by Type (2021-2026) & (K Tons) Table 21. Asia-Pacific Biopharmaceutical Excipients Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Biopharmaceutical Excipients Sales by Type (2021-2026) & (K Tons) Table 23. Latin America Biopharmaceutical Excipients Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Biopharmaceutical Excipients Sales by Type (2021-2026) & (K Tons) Table 25. Middle East and Africa Biopharmaceutical Excipients Sales by Type (2021-2026) & (US$ Million) Table 26. Biopharmaceutical Excipients Industry Trends Table 27. Biopharmaceutical Excipients Industry Drivers Table 28. Biopharmaceutical Excipients Industry Opportunities and Challenges Table 29. Biopharmaceutical Excipients Industry Restraints Table 30. Global Biopharmaceutical Excipients Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Biopharmaceutical Excipients Revenue Market Share by Company (2021-2026) Table 32. Global Biopharmaceutical Excipients Sales by Company (2021-2026) & (K Tons) Table 33. Global Biopharmaceutical Excipients Sales Share by Company (2021-2026) Table 34. Global Biopharmaceutical Excipients Market Price by Company (2021-2026) & (US$/Ton) Table 35. Global Biopharmaceutical Excipients Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Biopharmaceutical Excipients Major Company Production Sites and Headquarters Table 37. Global Biopharmaceutical Excipients Company, Product Type & Application Table 38. Global Biopharmaceutical Excipients Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Biopharmaceutical Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Biopharmaceutical Excipients Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Biopharmaceutical Excipients Sales by Region (2021-2026) & (K Tons) Table 43. Global Biopharmaceutical Excipients Sales Market Share in Volume by Region (2021-2026) Table 44. Global Biopharmaceutical Excipients Sales by Region (2021-2026) & (US$ Million) Table 45. Global Biopharmaceutical Excipients Sales Market Share in Value by Region (2021-2026) Table 46. Global Biopharmaceutical Excipients Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 47. Global Biopharmaceutical Excipients Sales by Region (2027-2032) & (K Tons) Table 48. Global Biopharmaceutical Excipients Sales Market Share in Volume by Region (2027-2032) Table 49. Global Biopharmaceutical Excipients Sales by Region (2027-2032) & (US$ Million) Table 50. Global Biopharmaceutical Excipients Sales Market Share in Value by Region (2027-2032) Table 51. Global Biopharmaceutical Excipients Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 52. Global Biopharmaceutical Excipients Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Biopharmaceutical Excipients Sales by Application (2021-2026) & (K Tons) Table 54. Global Biopharmaceutical Excipients Sales Market Share in Volume by Application (2021-2026) Table 55. Global Biopharmaceutical Excipients Sales by Application (2021-2026) & (US$ Million) Table 56. Global Biopharmaceutical Excipients Sales Market Share in Value by Application (2021-2026) Table 57. Global Biopharmaceutical Excipients Price by Application (2021-2026) & (US$/Ton) Table 58. Global Biopharmaceutical Excipients Sales by Application (2027-2032) & (K Tons) Table 59. Global Biopharmaceutical Excipients Sales Market Share in Volume by Application (2027-2032) Table 60. Global Biopharmaceutical Excipients Sales by Application (2027-2032) & (US$ Million) Table 61. Global Biopharmaceutical Excipients Sales Market Share in Value by Application (2027-2032) Table 62. Global Biopharmaceutical Excipients Price by Application (2027-2032) & (US$/Ton) Table 63. North America Biopharmaceutical Excipients Sales by Application (2021-2026) & (K Tons) Table 64. North America Biopharmaceutical Excipients Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Biopharmaceutical Excipients Sales by Application (2021-2026) & (K Tons) Table 66. Europe Biopharmaceutical Excipients Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Biopharmaceutical Excipients Sales by Application (2021-2026) & (K Tons) Table 68. Asia-Pacific Biopharmaceutical Excipients Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Biopharmaceutical Excipients Sales by Application (2021-2026) & (K Tons) Table 70. Latin America Biopharmaceutical Excipients Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Biopharmaceutical Excipients Sales by Application (2021-2026) & (K Tons) Table 72. Middle East and Africa Biopharmaceutical Excipients Sales by Application (2021-2026) & (US$ Million) Table 73. BASF SE Company Information Table 74. BASF SE Business Overview Table 75. BASF SE Biopharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. BASF SE Biopharmaceutical Excipients Product Portfolio Table 77. BASF SE Recent Development Table 78. ABITEC Corp Company Information Table 79. ABITEC Corp Business Overview Table 80. ABITEC Corp Biopharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. ABITEC Corp Biopharmaceutical Excipients Product Portfolio Table 82. ABITEC Corp Recent Development Table 83. Colorcon, Inc Company Information Table 84. Colorcon, Inc Business Overview Table 85. Colorcon, Inc Biopharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Colorcon, Inc Biopharmaceutical Excipients Product Portfolio Table 87. Colorcon, Inc Recent Development Table 88. DFE Pharma Company Information Table 89. DFE Pharma Business Overview Table 90. DFE Pharma Biopharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. DFE Pharma Biopharmaceutical Excipients Product Portfolio Table 92. DFE Pharma Recent Development Table 93. Meggle AG Company Information Table 94. Meggle AG Business Overview Table 95. Meggle AG Biopharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Meggle AG Biopharmaceutical Excipients Product Portfolio Table 97. Meggle AG Recent Development Table 98. Pharmonix Biological Company Information Table 99. Pharmonix Biological Business Overview Table 100. Pharmonix Biological Biopharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Pharmonix Biological Biopharmaceutical Excipients Product Portfolio Table 102. Pharmonix Biological Recent Development Table 103. Roquette Company Information Table 104. Roquette Business Overview Table 105. Roquette Biopharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Roquette Biopharmaceutical Excipients Product Portfolio Table 107. Roquette Recent Development Table 108. Sigachi Industries Company Information Table 109. Sigachi Industries Business Overview Table 110. Sigachi Industries Biopharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Sigachi Industries Biopharmaceutical Excipients Product Portfolio Table 112. Sigachi Industries Recent Development Table 113. Signet Chemical Corporation Company Information Table 114. Signet Chemical Corporation Business Overview Table 115. Signet Chemical Corporation Biopharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Signet Chemical Corporation Biopharmaceutical Excipients Product Portfolio Table 117. Signet Chemical Corporation Recent Development Table 118. Spectrum Chemical Manufacturing Corp Company Information Table 119. Spectrum Chemical Manufacturing Corp Business Overview Table 120. Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Product Portfolio Table 122. Spectrum Chemical Manufacturing Corp Recent Development Table 123. SPI Pharma Company Information Table 124. SPI Pharma Business Overview Table 125. SPI Pharma Biopharmaceutical Excipients Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. SPI Pharma Biopharmaceutical Excipients Product Portfolio Table 127. SPI Pharma Recent Development Table 128. North America Biopharmaceutical Excipients Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 129. North America Biopharmaceutical Excipients Sales by Country (2021-2026) & (K Tons) Table 130. North America Biopharmaceutical Excipients Sales Market Share by Country (2021-2026) Table 131. North America Biopharmaceutical Excipients Sales Forecast by Country (2027-2032) & (K Tons) Table 132. North America Biopharmaceutical Excipients Sales Market Share Forecast by Country (2027-2032) Table 133. North America Biopharmaceutical Excipients Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Biopharmaceutical Excipients Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Biopharmaceutical Excipients Market Share by Country (2021-2026) Table 136. North America Biopharmaceutical Excipients Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Biopharmaceutical Excipients Market Share Forecast by Country (2027-2032) Table 138. Europe Biopharmaceutical Excipients Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 139. Europe Biopharmaceutical Excipients Sales by Country (2021-2026) & (K Tons) Table 140. Europe Biopharmaceutical Excipients Sales Market Share by Country (2021-2026) Table 141. Europe Biopharmaceutical Excipients Sales Forecast by Country (2027-2032) & (K Tons) Table 142. Europe Biopharmaceutical Excipients Sales Market Share Forecast by Country (2027-2032) Table 143. Europe Biopharmaceutical Excipients Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Biopharmaceutical Excipients Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Biopharmaceutical Excipients Market Share by Country (2021-2026) Table 146. Europe Biopharmaceutical Excipients Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Biopharmaceutical Excipients Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Biopharmaceutical Excipients Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Biopharmaceutical Excipients Sales by Country (2021-2026) & (K Tons) Table 150. Asia-Pacific Biopharmaceutical Excipients Sales Market Share by Country (2021-2026) Table 151. Asia-Pacific Biopharmaceutical Excipients Sales Forecast by Country (2027-2032) & (K Tons) Table 152. Asia-Pacific Biopharmaceutical Excipients Sales Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Biopharmaceutical Excipients Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Biopharmaceutical Excipients Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Biopharmaceutical Excipients Market Share by Country (2021-2026) Table 156. Asia-Pacific Biopharmaceutical Excipients Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Biopharmaceutical Excipients Market Share Forecast by Country (2027-2032) Table 158. Latin America Biopharmaceutical Excipients Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 159. Latin America Biopharmaceutical Excipients Sales by Country (2021-2026) & (K Tons) Table 160. Latin America Biopharmaceutical Excipients Sales Market Share by Country (2021-2026) Table 161. Latin America Biopharmaceutical Excipients Sales Forecast by Country (2027-2032) & (K Tons) Table 162. Latin America Biopharmaceutical Excipients Sales Market Share Forecast by Country (2027-2032) Table 163. Latin America Biopharmaceutical Excipients Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Biopharmaceutical Excipients Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Biopharmaceutical Excipients Market Share by Country (2021-2026) Table 166. Latin America Biopharmaceutical Excipients Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Biopharmaceutical Excipients Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Biopharmaceutical Excipients Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Biopharmaceutical Excipients Sales by Country (2021-2026) & (K Tons) Table 170. Middle East and Africa Biopharmaceutical Excipients Sales Market Share by Country (2021-2026) Table 171. Middle East and Africa Biopharmaceutical Excipients Sales Forecast by Country (2027-2032) & (K Tons) Table 172. Middle East and Africa Biopharmaceutical Excipients Sales Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Biopharmaceutical Excipients Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Biopharmaceutical Excipients Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East and Africa Biopharmaceutical Excipients Market Share by Country (2021-2026) Table 176. Middle East and Africa Biopharmaceutical Excipients Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa Biopharmaceutical Excipients Market Share Forecast by Country (2027-2032) Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Biopharmaceutical Excipients Distributors List Table 181. Biopharmaceutical Excipients Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Biopharmaceutical Excipients Image Figure 2. Global Biopharmaceutical Excipients Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biopharmaceutical Excipients Market Size (2021-2032) & (US$ Million) Figure 4. Global Biopharmaceutical Excipients Sales (2021-2032) & (K Tons) Figure 5. Polyols Image Figure 6. Global Polyols Sales YoY Growth (2021-2032) & (K Tons) Figure 7. Carbohydrates Image Figure 8. Global Carbohydrates Sales YoY Growth (2021-2032) & (K Tons) Figure 9. Solubilizers& Surfactants/Emulsifiers Image Figure 10. Global Solubilizers& Surfactants/Emulsifiers Sales YoY Growth (2021-2032) & (K Tons) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (K Tons) Figure 13. Global Biopharmaceutical Excipients Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Biopharmaceutical Excipients Market Share by Type 2025 VS 2032 Figure 15. North America Biopharmaceutical Excipients Sales Market Share in Volume by Type in 2025 Figure 16. North America Biopharmaceutical Excipients Sales Market Share in Value by Type in 2025 Figure 17. Europe Biopharmaceutical Excipients Sales Market Share in Volume by Type in 2025 Figure 18. Europe Biopharmaceutical Excipients Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Biopharmaceutical Excipients Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Biopharmaceutical Excipients Sales Market Share in Value by Type in 2025 Figure 21. Latin America Biopharmaceutical Excipients Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Biopharmaceutical Excipients Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Biopharmaceutical Excipients Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Biopharmaceutical Excipients Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Biopharmaceutical Excipients Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Biopharmaceutical Downstream Image Figure 28. Global Biopharmaceutical Downstream Sales YoY Growth (2021-2032) & (K Tons) Figure 29. Biopharmaceutical Upstream Image Figure 30. Global Biopharmaceutical Upstream Sales YoY Growth (2021-2032) & (K Tons) Figure 31. Global Biopharmaceutical Excipients Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Biopharmaceutical Excipients Market Share by Application 2025 VS 2032 Figure 33. North America Biopharmaceutical Excipients Sales Market Share in Volume by Application in 2025 Figure 34. North America Biopharmaceutical Excipients Sales Market Share in Value by Application in 2025 Figure 35. Europe Biopharmaceutical Excipients Sales Market Share in Volume by Application in 2025 Figure 36. Europe Biopharmaceutical Excipients Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Biopharmaceutical Excipients Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Biopharmaceutical Excipients Sales Market Share in Value by Application in 2025 Figure 39. Latin America Biopharmaceutical Excipients Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Biopharmaceutical Excipients Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Biopharmaceutical Excipients Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Biopharmaceutical Excipients Sales Market Share in Value by Application in 2025 Figure 43. North America Biopharmaceutical Excipients Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 44. North America Biopharmaceutical Excipients Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Biopharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Biopharmaceutical Excipients Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Biopharmaceutical Excipients Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 48. Europe Biopharmaceutical Excipients Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Biopharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Biopharmaceutical Excipients Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Biopharmaceutical Excipients Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 52. Asia-Pacific Biopharmaceutical Excipients Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Biopharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Biopharmaceutical Excipients Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Biopharmaceutical Excipients Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 56. Latin America Biopharmaceutical Excipients Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Biopharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Biopharmaceutical Excipients Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Biopharmaceutical Excipients Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 60. Middle East and Africa Biopharmaceutical Excipients Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Biopharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Biopharmaceutical Excipients Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Biopharmaceutical Excipients Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Biopharmaceutical Excipients Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Polyols
  • Carbohydrates
  • Solubilizers& Surfactants/Emulsifiers
  • Other
Applications
  • Biopharmaceutical Downstream
  • Biopharmaceutical Upstream
Companies covered
  • BASF SE
  • ABITEC Corp
  • Colorcon, Inc
  • DFE Pharma
  • Meggle AG
  • Pharmonix Biological
  • Roquette
  • Sigachi Industries
  • Signet Chemical Corporation
  • Spectrum Chemical Manufacturing Corp
  • SPI Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biopharmaceutical Excipients Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Biopharmaceutical Excipients Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Biopharmaceutical Excipients Market by Type
  6. 1.3.1 Polyols
  7. 1.3.2 Carbohydrates
  8. 1.3.3 Solubilizers& Surfactants/Emulsifiers
  9. 1.3.4 Other
  10. 1.4 Global Biopharmaceutical Excipients Market Size by Type
  11. 1.4.1 Global Biopharmaceutical Excipients Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Biopharmaceutical Excipients Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Biopharmaceutical Excipients Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Biopharmaceutical Excipients Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Biopharmaceutical Excipients Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Biopharmaceutical Excipients Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Biopharmaceutical Excipients Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Biopharmaceutical Excipients Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Biopharmaceutical Excipients Industry Trends
  2. 2.2 Biopharmaceutical Excipients Industry Drivers
  3. 2.3 Biopharmaceutical Excipients Industry Opportunities and Challenges
  4. 2.4 Biopharmaceutical Excipients Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Biopharmaceutical Excipients Revenue (2021-2026)
  2. 3.2 Global Top Players by Biopharmaceutical Excipients Sales (2021-2026)
  3. 3.3 Global Top Players by Biopharmaceutical Excipients Price (2021-2026)
  4. 3.4 Global Biopharmaceutical Excipients Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biopharmaceutical Excipients Major Company Production Sites & Headquarters
  6. 3.6 Global Biopharmaceutical Excipients Company, Product Type & Application
  7. 3.7 Global Biopharmaceutical Excipients Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biopharmaceutical Excipients Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biopharmaceutical Excipients Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biopharmaceutical Excipients Tier 1, Tier 2, and Tier 3
4 Biopharmaceutical Excipients Regional Status and Outlook
  1. 4.1 Global Biopharmaceutical Excipients Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Biopharmaceutical Excipients Historic Market Size by Region
  3. 4.2.1 Global Biopharmaceutical Excipients Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Biopharmaceutical Excipients Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Biopharmaceutical Excipients Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Biopharmaceutical Excipients Forecasted Market Size by Region
  7. 4.3.1 Global Biopharmaceutical Excipients Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Biopharmaceutical Excipients Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Biopharmaceutical Excipients Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Biopharmaceutical Excipients by Application
  1. 5.1 Biopharmaceutical Excipients Market by Application
  2. 5.1.1 Biopharmaceutical Downstream
  3. 5.1.2 Biopharmaceutical Upstream
  4. 5.2 Global Biopharmaceutical Excipients Market Size by Application
  5. 5.2.1 Global Biopharmaceutical Excipients Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Biopharmaceutical Excipients Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Biopharmaceutical Excipients Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Biopharmaceutical Excipients Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Biopharmaceutical Excipients Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Biopharmaceutical Excipients Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Biopharmaceutical Excipients Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Biopharmaceutical Excipients Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BASF SE
  2. 6.1.1 BASF SE Company Information
  3. 6.1.2 BASF SE Business Overview
  4. 6.1.3 BASF SE Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BASF SE Biopharmaceutical Excipients Product Portfolio
  6. 6.1.5 BASF SE Recent Developments
  7. 6.2 ABITEC Corp
  8. 6.2.1 ABITEC Corp Company Information
  9. 6.2.2 ABITEC Corp Business Overview
  10. 6.2.3 ABITEC Corp Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ABITEC Corp Biopharmaceutical Excipients Product Portfolio
  12. 6.2.5 ABITEC Corp Recent Developments
  13. 6.3 Colorcon, Inc
  14. 6.3.1 Colorcon, Inc Company Information
  15. 6.3.2 Colorcon, Inc Business Overview
  16. 6.3.3 Colorcon, Inc Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Colorcon, Inc Biopharmaceutical Excipients Product Portfolio
  18. 6.3.5 Colorcon, Inc Recent Developments
  19. 6.4 DFE Pharma
  20. 6.4.1 DFE Pharma Company Information
  21. 6.4.2 DFE Pharma Business Overview
  22. 6.4.3 DFE Pharma Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 DFE Pharma Biopharmaceutical Excipients Product Portfolio
  24. 6.4.5 DFE Pharma Recent Developments
  25. 6.5 Meggle AG
  26. 6.5.1 Meggle AG Company Information
  27. 6.5.2 Meggle AG Business Overview
  28. 6.5.3 Meggle AG Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Meggle AG Biopharmaceutical Excipients Product Portfolio
  30. 6.5.5 Meggle AG Recent Developments
  31. 6.6 Pharmonix Biological
  32. 6.6.1 Pharmonix Biological Company Information
  33. 6.6.2 Pharmonix Biological Business Overview
  34. 6.6.3 Pharmonix Biological Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pharmonix Biological Biopharmaceutical Excipients Product Portfolio
  36. 6.6.5 Pharmonix Biological Recent Developments
  37. 6.7 Roquette
  38. 6.7.1 Roquette Company Information
  39. 6.7.2 Roquette Business Overview
  40. 6.7.3 Roquette Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Roquette Biopharmaceutical Excipients Product Portfolio
  42. 6.7.5 Roquette Recent Developments
  43. 6.8 Sigachi Industries
  44. 6.8.1 Sigachi Industries Company Information
  45. 6.8.2 Sigachi Industries Business Overview
  46. 6.8.3 Sigachi Industries Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sigachi Industries Biopharmaceutical Excipients Product Portfolio
  48. 6.8.5 Sigachi Industries Recent Developments
  49. 6.9 Signet Chemical Corporation
  50. 6.9.1 Signet Chemical Corporation Company Information
  51. 6.9.2 Signet Chemical Corporation Business Overview
  52. 6.9.3 Signet Chemical Corporation Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Signet Chemical Corporation Biopharmaceutical Excipients Product Portfolio
  54. 6.9.5 Signet Chemical Corporation Recent Developments
  55. 6.10 Spectrum Chemical Manufacturing Corp
  56. 6.10.1 Spectrum Chemical Manufacturing Corp Company Information
  57. 6.10.2 Spectrum Chemical Manufacturing Corp Business Overview
  58. 6.10.3 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Product Portfolio
  60. 6.10.5 Spectrum Chemical Manufacturing Corp Recent Developments
  61. 6.11 SPI Pharma
  62. 6.11.1 SPI Pharma Company Information
  63. 6.11.2 SPI Pharma Business Overview
  64. 6.11.3 SPI Pharma Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 SPI Pharma Biopharmaceutical Excipients Product Portfolio
  66. 6.11.5 SPI Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Biopharmaceutical Excipients Sales by Country
  2. 7.1.1 North America Biopharmaceutical Excipients Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Biopharmaceutical Excipients Sales by Country (2021-2026)
  4. 7.1.3 North America Biopharmaceutical Excipients Sales Forecast by Country (2027-2032)
  5. 7.2 North America Biopharmaceutical Excipients Market Size by Country
  6. 7.2.1 North America Biopharmaceutical Excipients Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Biopharmaceutical Excipients Market Size by Country (2021-2026)
  8. 7.2.3 North America Biopharmaceutical Excipients Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Biopharmaceutical Excipients Sales by Country
  2. 8.1.1 Europe Biopharmaceutical Excipients Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Biopharmaceutical Excipients Sales by Country (2021-2026)
  4. 8.1.3 Europe Biopharmaceutical Excipients Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Biopharmaceutical Excipients Market Size by Country
  6. 8.2.1 Europe Biopharmaceutical Excipients Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Biopharmaceutical Excipients Market Size by Country (2021-2026)
  8. 8.2.3 Europe Biopharmaceutical Excipients Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Biopharmaceutical Excipients Sales by Country
  2. 9.1.1 Asia-Pacific Biopharmaceutical Excipients Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Biopharmaceutical Excipients Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Biopharmaceutical Excipients Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Biopharmaceutical Excipients Market Size by Country
  6. 9.2.1 Asia-Pacific Biopharmaceutical Excipients Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Biopharmaceutical Excipients Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Biopharmaceutical Excipients Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Biopharmaceutical Excipients Sales by Country
  2. 10.1.1 South America Biopharmaceutical Excipients Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Biopharmaceutical Excipients Sales by Country (2021-2026)
  4. 10.1.3 South America Biopharmaceutical Excipients Sales Forecast by Country (2027-2032)
  5. 10.2 South America Biopharmaceutical Excipients Market Size by Country
  6. 10.2.1 South America Biopharmaceutical Excipients Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Biopharmaceutical Excipients Market Size by Country (2021-2026)
  8. 10.2.3 South America Biopharmaceutical Excipients Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Biopharmaceutical Excipients Sales by Country
  2. 11.1.1 Middle East and Africa Biopharmaceutical Excipients Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Biopharmaceutical Excipients Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Biopharmaceutical Excipients Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Biopharmaceutical Excipients Market Size by Country
  6. 11.2.1 Middle East and Africa Biopharmaceutical Excipients Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Biopharmaceutical Excipients Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Biopharmaceutical Excipients Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Biopharmaceutical Excipients Value Chain Analysis
  2. 12.1.1 Biopharmaceutical Excipients Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Biopharmaceutical Excipients Production Mode & Process
  7. 12.2 Biopharmaceutical Excipients Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Biopharmaceutical Excipients Distributors
  10. 12.2.3 Biopharmaceutical Excipients Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst